Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.
Pitocco
D
D
Internal Medicine Institute, Catholic University, L. go A. Gemelli 8, Rome, Italy. dario.pitocco@rm.unicatt.it
Collina
M C
MC
Musella
T
T
Ruotolo
V
V
Caputo
S
S
Manto
A
A
Caradonna
P
P
Galli
M
M
Mancini
L
L
Ghirlanda
G
G
D000208:Acute Disease; D019386:Alendronate / Q000627:therapeutic use*; D001177:Arthropathy, Neurogenic / Q000188:drug therapy* / Q000378:metabolism; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001862:Bone Resorption / Q000188:drug therapy*; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007249:Inflammation; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*
D050071:Bone Density Conservation Agents; D007334:Insulin-Like Growth Factor I; D019386:Alendronate